| Project Title | Angiotensin II Receptor Blockers and Celiac Disease |
| Date Posted | Monday, January 16, 2012 |
| Status | Complete |
| Deliverables | |
| Description | Modular program-based one-time assessment of the risk of celiac disease associated with new use of angiotensin II receptor blockers (ARBs). Modular programs are adaptable standardized programs. |
| Medical Product | angiotensin II receptor blocker (ARB) candesartan eprosartan irbesartan losartan olmesartan telmisartan valsartan |
| Health Outcome | celiac disease |
| Assessment Type | Exploratory Analyses |
| Study Type | Modular Program |
| Data Sources | Mini-Sentinel Distributed Dataset (MSDD) |
| FDA Center | CDER |
